Literature DB >> 26156226

A pilot study about speech changes after partial Tucker's laryngectomy: the reduction of regressive voicing assimilation.

C Galant1,2, A Lagier3,4, C Vercasson5,6, L Santini4, P Dessi4, A Giovanni3,4, N Fakhry3,4.   

Abstract

Partial frontolateral laryngectomy (PL) is performed to remove larynx tumor while preserving its main functions. So far, the speech changes induced by difficulties of voicing and the alterations to the vocal tract due to PL have been seldom addressed. The goal of our study was to make an acoustic analysis of regressive voicing assimilation (RVA) among patients after PL and to study the relationship with rates of speech. A retrospective study was conducted from January to April 2013. 11 subjects treated by partial frontolateral laryngectomy, and ten healthy subjects were included. Functional recordings of voice were analyzed and compared. For assimilation sequences we found a significant modification of voicing ratio in healthy subjects (p < 0.05) and PL patient at accelerated speaking rate only (p < 0.05). The vowel duration is significantly modified only for healthy subjects. For all subjects (PL patients and healthy) the duration of C1 consonant was not significantly modified. Our results highlight the presence of RVA in healthy subjects, but also in PL patients in the rapid speaking mode.

Entities:  

Keywords:  Alaryngeal speech; Laryngectomy; Linguistics; Phonetics; Speech therapy

Mesh:

Year:  2015        PMID: 26156226     DOI: 10.1007/s00405-015-3702-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  Voice and swallowing after partial laryngectomy: factors influencing outcome.

Authors:  Matteo Alicandri-Ciufelli; Alessia Piccinini; Alberto Grammatica; Andrea Chiesi; Giuseppe Bergamini; Maria Pia Luppi; Federica Nizzoli; Angelo Ghidini; Sauro Tassi; Livio Presutti
Journal:  Head Neck       Date:  2012-02-06       Impact factor: 3.147

2.  Acoustic and aerodynamic measurement of speech production after supracricoid partial laryngectomy.

Authors:  Marc Makeieff; Eric Barbotte; Antoine Giovanni; Bernard Guerrier
Journal:  Laryngoscope       Date:  2005-03       Impact factor: 3.325

3.  Correlation between coping strategies and subjective assessment of the voice-related quality of life of patients after resection of T1 and T2 laryngeal tumours.

Authors:  E Seiferlein; T Haderlein; M Schuster; E Gräßel; C Bohr
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-27       Impact factor: 2.503

4.  [Preliminary study of acoustic and aerodynamic parameters after Tucker frontal anterior laryngectomy].

Authors:  A Giovanni; D Robert; B Teston; M D Guarella; M Zanaret
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  1996

5.  Glottic reconstruction after near total laryngectomy.

Authors:  H M Tucker; B G Wood; H Levine; R Katz
Journal:  Laryngoscope       Date:  1979-04       Impact factor: 3.325

6.  Quality of life of patients with laryngeal carcinoma: a post-treatment study.

Authors:  R Müller; J Paneff; V Köllner; R Koch
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-08       Impact factor: 2.503

7.  Objective evaluation of the quality of substitution voices.

Authors:  Mieke Moerman; Glenn Pieters; Jean-Pierre Martens; Marie-Jeanne Van der Borgt; Phillippe Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-15       Impact factor: 2.503

8.  Evaluation of voice and speech following subtotal reconstructive laryngectomy.

Authors:  A Pastore; A V Yuceturk; P Trevisi
Journal:  Eur Arch Otorhinolaryngol       Date:  1998       Impact factor: 2.503

9.  Analysis of swallowing after partial frontolateral laryngectomy with epiglottic reconstruction for glottic cancer.

Authors:  Nicolas Fakhry; Justin Michel; Roch Giorgi; Danielle Robert; Aude Lagier; Laure Santini; Eric Moreddu; Laurent Puymerail; Pascal Adalian; Patrick Dessi; Antoine Giovanni
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-08       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.